Land: Japan
Tungumál: enska
Heimild: すりの適正使用協議会 RAD-AR Council, Japan
Ursodeoxycholic acid
TOWA PHARMACEUTICAL CO., LTD.
Ursodeoxycholic acid
white tablet, diameter: 6.0mm, thickness: 2.9mm
Print on wrapping: Tw.U01,ウルソデオキシコール酸50mg,50mg,Ursodeoxycholic Acid 50
Drug Information Sheet("Kusuri-no-Shiori") Internal Revised: 01/2019 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. BRAND NAME: URSODEOXYCHOLIC ACID TABLETS 50MG "TOWA" ACTIVE INGREDIENT: Ursodeoxycholic acid DOSAGE FORM: white tablet, diameter: 6.0mm, thickness: 2.9mm IMPRINT OR PRINT ON WRAPPING: Tw.U01,ウルソデオキシコール酸 50mg,50mg,Ursodeoxycholic Acid 50 EFFECTS OF THIS MEDICINE This medicine increases bile secretion and thereby improves the bile flow. This medicine replaces hydrophobic bile acids in the liver, resulting in alleviation of hepatotoxicity. Moreover, this medicine inhibits cytokine/chemokine production and the infiltration of inflammatory cells into the liver, leading to improvement of liver dysfunction. In addition to these effects, this medicine provides dissolution of gallstones and improvement of digestion and absorption. Usually, it is used to treat disease of biliary system and liver disease resulting from bile flow retention, improve dyspepsia after small intestine resection and that in inflammatory disease of small intestine, dissolve cholesterol gallstones, and improve liver function in chlonic liver disease, primary biliary cirrhosis and chronic liver disease due to hepatitis C virus. THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS MEDICINE.BE SURE TO TELL YOUR DOCTOR AND PHARMACIST. ・If you ever experienced any allergic reaction (itch, rash etc.) to any medicines or foods. If you are patient with complete biliary obstruction or fulminant hepatitis. ・If you are pregnant or breastfeeding. ・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. B Lestu allt skjalið